|
|
 |
|
Viewing report
|
|
|
|
Choosing the proper long-term manufacturing strategy - system comparison
CredoLegal, Jan 2004, Pages: 27
All antibodies currently on the market are manufactured by the mammalian cell culture technology, and it is clearly the leading technology at the moment. However, there are a number of negative factors linked to this technology that can be minimized or avoided by using other production technologies. The mammalian cell culture technology is represented by a strategic overview-based approach in comparison with the transgenic plant and animal platforms.
Multiple factors affecting manufacturing decisions by potential clients are highlighted in our analysis:
-The cost of setting up the manufacturing platform (initial capital outlay)
-Scaling up the manufacturing process
-The expression level of biologics
-Purification costs
-Validation, regulation, environmental and ethical concerns
-Therapeutic safety (immunogenicity) and activity of the protein product in relation to glycosylation
-Intellectual property hurdles
The actual cost associated with transgenic therapeutics can be significantly higher than expected due to the substantial significance of purification. Creative purification technologies such as purification by centrifugation, protein crystallization, fusion to protein-based polymers, which aggregate upon temperature shift, or fusion to oilbodies and oilbody-linked ligands might create a greater cost advantage for transgenic systems.
Above mentioned multiple factors affecting manufacturing decisions by potential clients are highlighted and analyzed in Choosing the proper long-term manufacturing strategy - system comparison –business intelligence analysis.
The report details key issues driving manufacturing investment in the pharmaceutical sector. Analysis includes thorough business intelligence analysis of technology solutions that can be consolidated into a (finite) number of areas. Vendors need to be able to approach customers with an understanding of industry dynamics, and how their solutions will address them. By reading the analysis you are able to understand the key areas that will drive the growth of transgenic manufacturing industry in the next 5 years and plan your strategy accordingly.
Customers who bought this item also bought
Financial Modelling and Evaluation of Transgenic Manufacturing
Partnering and business trends in transgenic manufacturing
Chinese Markets for Polybutadiene Rubber (BR)
Transgenic manufacturing the whole analysis
Br. Holdings Corporation
Br Malls Participacoes Sa
Mammalian Cell Culture: Production Technologies and Market Overview
Operating tools for transgenic manufacturers
Next-Generation Biologics: Improving on Monoclonal Antibodies
Protein Therapeutics Production: Large-scale Mammalian Cell Culture
Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success
European Protein Purification Markets
|
|
|
|
